Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
206
-
Total shares
-
204M
-
Shares change
-
+32.8M
-
Total reported value, excl. options
-
$180M
-
Value change
-
+$27.3M
-
Put/Call ratio
-
1.58
-
Number of buys
-
99
-
Number of sells
-
-76
-
Price
-
$0.89
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q4 2022
207 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q4 2022.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 204M shares
.
Largest 10 shareholders include STATE STREET CORP (50.6M shares), BlackRock Inc. (39.4M shares), VANGUARD GROUP INC (29.5M shares), GEODE CAPITAL MANAGEMENT, LLC (8.91M shares), B. Riley Financial, Inc. (5.22M shares), B. Riley Securities, Inc. (5.22M shares), D. E. Shaw & Co., Inc. (5.11M shares), Rafferty Asset Management, LLC (4.39M shares), NORTHERN TRUST CORP (4.18M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (3.51M shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.